The number of reported consolidated quarters for Chintan Pharma Chem tatva is:
Net sales at RS 88.40 Crore in June 2022 fell 17.25% from the hospital. 106.83 Crore in June 2021.
Quarterly Net Profit at the Hospital. 9.80 crore in June 2022 fell 57.67% from the hospital. 23.15 Crore in June 2021.
Ebitda stood in the hospital. 17.04 Crore in June 2022 dropped 40.83% from the hospital. 28.80 Crore in June 2021.
Tatva Chintan EPS has declined to a hospital. 4.42 in June 2022 from the hospital. 11.52 in June 2021
Tatva Chintan shares closed at 2,370.50 on July 25, 2022 (NSE) and had given a return of -1.61% over the past 6 months and 2.52% over the past 12 months.